Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

for
Healthy Volunteer, Prostate Cancer, Head and Neck Cancer,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT04354064

Recruiting

Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors

for
Solid Tumor
Location: Philadelphia PA, Norfolk VA, Pittsburgh PA, Tampa FL,
Sponsor: ImmunoGenesis

Sex: All

Age: 18+

Code: NCT06014502

Phase 1, Recruiting

Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06184321

Early Phase 1, Recruiting

A Randomized Trial of a Mobile Health Exercise Intervention for Older Adults With Myeloid Neoplasms

for
Cancer, Myeloid Neoplasm
Location: Rochester NY
Sponsor: University of Rochester

Sex: All

Age: 60+

Code: NCT04981821

Recruiting

Intra- and Inter-fraction Changes in Radiation Therapy

for
Cancer
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 0+

Code: NCT02344121

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer

for
Neoplasms, Healthy
Location: New York NY, Syracuse NY
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07258836

Phase 1, Recruiting

Acupressure for the Reduction of Anxiety in Patients Receiving Cancer-Directed Therapy

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06723041

Recruiting

Mindful Waiting Room

for
Anxiety State, Depressive State, Pain, Nausea, Fatigue, Cancer
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT05433636

Recruiting

Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma

for
Classical Hodgkin Lymphoma, Relapsed Cancer, Refractory Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT04510636

Phase 2, Recruiting

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

for
Differentiated Thyroid Cancer, Pediatric Cancer, Cancer,
Location: Philadelphia PA, Memphis TN, Houston TX
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 2 - 25

Code: NCT06458036

Phase 2, Recruiting

Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer

for
Pancreatic Cyst, Pancreas Disease
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT03260842

Recruiting

mychoiceTM Implementation With Medical Oncology Patients

for
Cancer
Location: Philadelphia PA
Sponsor: Fox Chase Cancer Center

Sex: All

Age: 18+

Code: NCT06222242

Recruiting

Prospective Validation of a Points Score System Predicting 30-day Survival

for
Metastatic Cancer
Location: Indianapolis IN, Carmel IN, Avon IN
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT05100342

Recruiting

Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Baltimore MD, Orlando FL, Columbus OH, Aurora CO,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06233942

Phase 1, Recruiting

A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)

for
Neoplasms
Location: Boston MA, New Haven CT, Sherbrooke, New Brunswick NJ,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06551142

Phase 1, Recruiting

Integration of Exercise Into Cancer Care: A Shared Care Model

for
Cancer
Location: La Crosse WI
Sponsor: Landspitali University Hospital

Sex: All

Age: 18+

Code: NCT03661242

Recruiting

Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer

for
Non-GI Cancers, Cancer of Gastrointestinal Tract,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT01313442

Recruiting

CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)

for
Cancer, Malignancies Multiple, Malignant Solid Tumor,
Location: Halifax, Fredericton, Sherbrooke, Montreal, Ottawa,
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT04151342

Recruiting

eMOTION: Examining Affective Mechanisms in Physical Activity Engagement

for
Physical Inactivity, Overweight or Obesity, Cancer
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 18+

Code: NCT06570642

Recruiting

A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients

for
Solid Tumor
Location: Houston TX, Dallas TX, Lewisville TX, Glendale CA
Sponsor: Teligene US

Sex: All

Age: 18+

Code: NCT06010342

Phase 2, Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial